Coronavirus Now: COVID-19 Updates for August 7

As of August 7, confirmed cases of COVID-19 now number at more than 19 million around the world, including more than 5 million cases in the United States and more than 162,000 U.S. deaths. You can see a breakdown of coronavirus cases throughout the world and within the U.S. on the map and chart above.

Below you’ll find updates on the latest news about the coronavirus.


August 7 News Updates

More than 5 Million Cases Reported in the United States

The United States has now surpassed 5 million confirmed coronavirus cases, including 162,000 deaths. The U.S. tops the world in cases, with Brazil being the next highest with 2.9 million cases, followed by India with 2 million cases.

In the United States, California has the most total cases with more than 541,000, followed by Florida with more than 510,000, and Texas with more than 489,000. New York still had the most deaths with 32,817, followed by New Jersey with 15,923 deaths, and California with 10,028 deaths.

Mississippi Teacher Dies from Coronavirus & Florida Coach Is in a Coma

In Mississippi, a Layfayette County teacher died while self-quarantining for COVID-19, Mississippi Today reported. Nacoma James, 42, an assistant high school coach and teacher, had not yet returned to school. The last contact he’d had with students had been at summer football workouts.

In Florida, Apopka High School Coach Bill Neeley is in a medically induced coma while battling COVID-19, Fox 35 reported. Neeley went to the hospital with breathing problems and had pneumonia. A GoFundMe has been set up to help with medical expenses. The latest update said he’s stable and showing a little improvement.

Priest Gets COVID-19 After Telling Congregants Who Didn’t Come to Chuch that Their Faith Was ‘Lukewarm’

Monsignor Charles Pope of Holy Comforter St Cyprian Catholic Church in Washington D.C. had told congregants that their faith was “lukewarm” if they didn’t come to church, Independent reported. He was later diagnosed and hospitalized for COVID-19 on July 27. He’s since been released and is self-isolating at home.

VideoVideo related to coronavirus now: covid-19 updates for august 72020-02-28T02:54:57-05:00

Pope had questioned whether coronavirus restrictions went too far. In a YouTube video, he later said he followed all the safety protocols, including wearing a mask, and wasn’t sure how he got the virus.

Vaccine Updates

GettyA woman leaves Life Care Center of Kirkland on February 29, 2020, in Kirkland, Washington.

Novavax announced that in its Phase 1 vaccine trial for NVX-CoV2373, antibodies were induced in 100% of participants, The Motley Fool reported. The vaccine had mild side effects, typically worse with the second dose.

Moderna’s new vaccine has shown promise in early trials of eight volunteers who received two doses, The New York Times reported. The vaccine showed a safe immune response. The trial will now be repeated with hundreds and later thousands of people in a July trial. The vaccine uses mRNA from the virus, which is a new process. The earliest a Moderna vaccine might be available would be the end of this year or early 2021.

Oxford University researchers have tested a vaccine that successfully works in monkeys and is being tested in Britain volunteers, WUSA9 reported in late April. If all goes well, the first few million doses could be ready as soon as September. The vaccine uses genes from a spikey protein to help the immune system make antibodies.

Bill Gates is funding factories that will test seven vaccine candidates to help mobilize vaccines faster, Business Insider reported in early April. He said: “Even though we’ll end up picking at most two of them, we’re going to fund factories for all seven, just so that we don’t waste time.”

A second potential COVID-19 vaccine is from Inovio, called the INO-4800 DNA vaccine. Inovio completed Phase 1 trial for a similar DNA vaccine for MERS. The Bill and Melinda Gates Foundation is backing this trial. Inovio announced positive results from two Phase I clinical trials in early July. The Phase 1 trial has now been expanded to include older participants, and Phase 2/3 may begin this summer. The Phase 1 trial had 40 healthy volunteers ages 18 to 50 who had 1 mg and 2 mg cohorts, with two doses taken four weeks apart. All were safe through week 8 and only 10 had minor adverse events, mostly just redness at the injection site. Analyses showed 94% had immunological response rates. The vaccine has also been shown to protect mice, preventing viral replication in their lungs.

On March 30, Johnson & Johnson announced that it will start human clinical trials for a vaccine in September, with the first round not being available until early 2021.

A clinical vaccine trial funded by NIH at Kaiser Permanente in Washington began on Monday, March 16. Forty-five people participated in the first round. The vaccine candidate code is mRNA-1273. As of May 1, about 2/3 of the participants had gotten their first of two doses, NBC News reported.

Israeli scientists have said they may be close to a vaccine, The Jerusalem Post reported. Scientists have been working on a vaccine against a bronchial disease that affected poultry. Dr. Chen Katz told The Jerusalem Post that out of luck, they had chosen a coronavirus as the proof of concept for their technology, and the DNA of COVID-19 is very similar.

Greffex in Houston has a potential vaccine ready for animal testing, Yahoo! reported. And Walter Reed and the U.S. Army have been conducting animal studies since January.


Coronavirus Trends in the United States

An interactive map from MappingSupport.com shows recent trends in deaths per state over the last 14 and 7 days. You can view the full map here. Green means the trend is decreasing, red means the deaths are increasing. Circles show the prior 14 days and triangles show the prior seven days.


Open this map full screen.

Another map sourcing the most recent news about the virus can be found here.

If you are concerned about your symptoms, talk with your doctor right away.

READ NEXT: Best N95 Masks & Respirators to Keep You Safe